Literature DB >> 7377833

Chondrodysplasia punctata after warfarin in early pregnancy. Case report and summary of the literature.

M F Whitfield.   

Abstract

A third case of chondrodysplasia punctata after exposure to warfarin alone in early pregnancy is described. The clinical course of the child during the first 18 months is outlined. The use of warfarin in early pregnancy must be avoided because of its established teratogenic effects in causing this syndrome, in addition to an overall increase in perinatal mortality.

Entities:  

Mesh：

Substances：

Year:  1980        PMID： 7377833      PMCID： PMC1626683          DOI： 10.1136/adc.55.2.139

Source DB:  PubMed          Journal:  Arch Dis Child        ISSN： 0003-9888            Impact factor:   3.791


  13 in total

1.  Chondrodysplasia punctata and maternal warfarin use during pregnancy.

Authors:  W L Shaul; H Emery; J G Hall
Journal:  Am J Dis Child       Date:  1975-03

2.  Chondrodysplasis punctata: is maternal warfarin therapy a factor?

Authors:  M H Becker; N B Genieser; M Finegold; D Miranda; T Spackman
Journal:  Am J Dis Child       Date:  1975-03

3.  Letter: Fetal anomalies associated with warfarin therapy initiated shortly prior to conception.

Authors:  E M Richman; J E Lahman
Journal:  J Pediatr       Date:  1976-03       Impact factor: 4.406

4.  Pregnancy in a patient with a prosthetic mitral valve. Associated with a fetal anomaly attributed to warfarin sodium.

Authors:  I J Kerber; O S Warr; C Richardson
Journal:  JAMA       Date:  1968-01-15       Impact factor: 56.272

5.  Effects of coumarin compounds on the fetus.

Authors:  S J Fillmore; E McDevitt
Journal:  Ann Intern Med       Date:  1970-11       Impact factor: 25.391

6.  Heterogeneity of Chondrodysplasia punctata.

Authors:  J W Spranger; J M Opitz; U Bidder
Journal:  Humangenetik       Date:  1971

7.  Relationship of maternal warfarin therapy in pregnancy to chondrodysplasia punctata: report of a case.

Authors:  P Collins; R Olufs; H Karvitz; M Babakitis
Journal:  Am J Obstet Gynecol       Date:  1977-02-15       Impact factor: 8.661

8.  Warfarin therapy initiated during pregnancy and phenotypic chondrodysplasia punctata.

Authors:  R M Pauli; J D Madden; K J Kranzler; W Culpepper; R Port
Journal:  J Pediatr       Date:  1976-03       Impact factor: 4.406

9.  Congenital malformations associated with the administration of oral anticoagulants during pregnancy.

Authors:  J M Pettifor; R Benson
Journal:  J Pediatr       Date:  1975-03       Impact factor: 4.406

10.  Chondrodysplasia punctata-23 cases of a mild and relatively common variety.

Authors:  L J Sheffield; D M Danks; V Mayne; A L Hutchinson
Journal:  J Pediatr       Date:  1976-12       Impact factor: 4.406
View more
  4 in total

1.  Monitoring and avoiding drug and chemical teratogenicity.

Authors:  G Koren; S M MacLeod
Journal:  CMAJ       Date:  1986-11-15       Impact factor: 8.262

2.  Low-molecular-weight heparin versus warfarin for prevention of recurrent venous thromboembolism: a randomized trial.

Authors:  S K Das; A T Cohen; R A Edmondson; E Melissari; V V Kakkar
Journal:  World J Surg       Date:  1996-06       Impact factor: 3.352

3.  Chondrodysplasia punctata after warfarin. Case report with 18-month follow-up.

Authors:  O Tamburrini; A Bartolomeo-De Iuri; G L Di Guglielmo
Journal:  Pediatr Radiol       Date:  1987

Review 4.  Anticoagulation during pregnancy in patients with a prosthetic heart valve.

Authors:  Jose M Castellano; Rajeev L Narayan; Prashant Vaishnava; Valentin Fuster
Journal:  Nat Rev Cardiol       Date:  2012-05-15       Impact factor: 32.419
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.